US FDA News: Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems – FDA Safety Communication

Do not routinely use AFX2 endovascular grafts for patients with abdominal aortic aneurysms.
Read more: Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems – FDA Safety Communication